The independent source for health policy research, polling, and news.
6,841 - 6,860 of 15,445 Results
The Trump administration is pulling out an old regulation that it believes will be able to meet a key conservative goal: withholding some federal funding for Planned Parenthood in the government’s family planning program.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
A crowdsourced investigation by KHN and NPR gives voice to those who are puzzled and outraged by medical invoices.
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
The first-in-the-nation measure would empower Vermont to set up a wholesale program to import prescription drugs from Canada. But it still will have to get federal buy-in before it is operational.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Opioid addiction is often portrayed as a white problem, but overdose rates are now rising faster among Latinos and blacks. Cultural and linguistic barriers may put Latinos at greater risk.
Rates of gonorrhea, syphilis and chlamydia in California have shot up 45 percent over five years, resulting in 30 syphilis-related stillbirths in 2017 alone, new state data show.
In a case with possible national repercussions, the state’s attorney general has sued over alleged price gouging, and other legal and legislative challenges are afoot. Sutter is pushing back hard, denying anticompetitive behavior.
Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
As many as 16 million people in the United States have undiagnosed or uncorrected vision problems that could be fixed with eyeglasses, contact lenses or surgery.
Older adults often feel invisible as their interactions with younger people dwindle and hardly anyone seems to seek their advice. To make matters worse, studies link loneliness to weaker immune systems and poorer physical health.
A woman with foot pain was floored by the high cost of titanium screws used in her surgery. “Unless the metal [was] mined on an asteroid, I do not know why it should cost that amount,” she says.
A judge orders the county to fix problem that harmed low-income seniors and people with disabilities, including those with serious health conditions.
Advocates in Oregon and Denver are pushing ballot measures to allow possession of mushrooms containing the hallucinogenic ingredient psilocybin, as new research shows it may be useful in treating depression and anxiety. Supporters of a measure to decriminalize magic mushrooms in California ended their effort late last month.
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Promises to control pharma prices threaten profits for Switzerland-based Novartis, which sells some of the costliest drugs in the world.
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
A proposed change in immigration policy from the Trump administration could make it more difficult for immigrants to obtain a green card if family members use Medicaid or other government benefits for medical care.
© 2026 KFF